Toby Maher

His research interests include clinical trials, biomarker discovery, the lung microbiome and host immune response in the pathogenesis of IPF and clinical trials in fibrotic lung disease. He is an associate editor for American Journal of Respiratory and Critical Care Medicine. He has authored over 260 papers and book chapters on IPF.